NOTVQ · Inotiv, Inc.
$0.01
At close · Jul 17
Going-concern doubt
— flagged May 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, substantial doubt about the Company's ability to continue as a going concern exists.”View the 10-Q filed May 11, 2026
Market Cap
$387,258
Shares
34.89M
NOTVQ metrics
48 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.01
Market cap
$387,258
Price action
19 metricsPrice change (1W)
—
Price change (30D)
—
Price change (3M)
—
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
—
Beta
—
RSI (14D)
—
Price vs SMA 50
—
Price vs SMA 200
—
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—
Company
3 metricsSector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
34.89M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.8×
reciprocal yield 128.2%
EV / EBITDA
51.4×
reciprocal yield 1.9%
EV / EBIT
—
P / sales
0.0×
reciprocal yield 131,012.3%
P / book
0.0
reciprocal yield 19,908.9%
FCF yield
-3,515.0%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
1.1
reciprocal yield 91.4%
Earnings yield
-22,458.9%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-02-09
Profitability
9 metricsGross margin
—
Operating margin
-9.5%
Trailing 12 months
Net margin
-17.1%
Gross profit (TTM)
$30.16M
Operating profit (TTM)
−$48.10M
Net income (TTM)
−$86.97M
Trailing 12 months
Diluted EPS (TTM)
$-2.42
FCF margin
-2.7%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-5.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
$507.36M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1.9%
Year over year · more shares
Revenue CAGR (3Y)
-2.2%
Revenue CAGR (5Y)
+53.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-112.8%
Return on assets
-12.4%
Debt / equity
5.3
Current ratio
0.3
EBITDA (TTM)
$7.70M
Free cash flow (TTM)
−$13.61M
Quick ratio
0.2
Interest coverage
-0.8
Net debt / EBITDA
51.3
Return on invested capital
—
Trailing 12 months
Net cash
−$395.24M
Latest balance sheet
Cash & equivalents
$15.18M
Total assets
$702.42M
Total debt
$410.42M
Cash flow & spend
7 metricsOperating cash flow (TTM)
$354,000
Capital expenditures (TTM)
$13.97M
R&D (TTM)
$405,000
SG&A (TTM)
—
Stock compensation (TTM)
$5.41M
R&D / revenue
—
Stock compensation / revenue
1.1%
Ownership (13F)
3 metrics13F filers
3
13F filer change QoQ
-48
Institutional ownership
0.1%
Short interest
3 metricsShort interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
Flagged